title: Developing practice guidelines for the administration of intravenous immunoglobulin.
abstract: As the use of intravenous immunoglobulin (IGIV) continues to expand, infusion nurses have a greater need for a comprehensive understanding of the product, patient risk factors, and comorbidities when developing guidelines for administering IGIV. Because immunoglobulin therapy is a blood derivative product, many nurses may not have as much experience administering this type of infusion. This article provides an in-depth overview of immunoglobulin therapy and helps to define the infusion nurse's major role in coordinating, assessing, and ensuring patient safety during IGIV administration.
authors.affiliation: elyse.murphy@zibbehring.com
authors.forename: Elyse
authors.initials: E
authors.lastname: Murphy
authors.forename: Sarah
authors.initials: S
authors.lastname: Martin
authors.forename: Jardiolyn Valino
authors.initials: JV
authors.lastname: Patterson
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000707:Anaphylaxis / Q000139:chemically induced; D002985:Clinical Protocols / Q000592:standards; D004334:Drug Administration Schedule; D005440:Fluid Therapy / Q000451:nursing; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy / Q000451:nursing; D007262:Infusions, Intravenous / Q000451:nursing; D008582:Meningitis, Aseptic / Q000139:chemically induced; D024802:Nurse's Role; D010347:Patient Care Planning; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D013041:Specialties, Nursing / Q000458:organization & administration; D013923:Thromboembolism / Q000139:chemically induced
chemical_list: D016756:Immunoglobulins, Intravenous